Directory
>
John Hadcock
John Hadcock
Vice President, Nonclinical Development at Prime Medicine | Prime Medicine, Inc.
United States
John Hadcock
Summary
John Hadcock is an accomplished Vice President of Nonclinical Development at Prime Medicine, bringing over 30 years of extensive experience in drug discovery and development, particularly in RNA therapeutics and small molecules. He has been instrumental in leading teams that achieved five drug approvals and has a strong track record in advancing candidates through IND-enabling studies to clinical proof of concept. With expertise spanning various disease areas, including rare genetic disorders and metabolic diseases, John has published over 70 peer-reviewed works and holds 15 patents. His leadership roles in multiple organizations highlight his strategic vision and ability to drive innovation in the life sciences sector. He is also recognized for his contributions to regulatory processes, having served as a line function reviewer for numerous INDs and NDAs. John's commitment to scientific advancement is matched by his dedication to mentoring the next generation of scientists in the field.
John Hadcock
Work Experience
Vice President, Nonclinical Development at Prime Medicine at
Prime Medicine, Inc.
January 2023 - Present
Vice President, Nonclinical Development and Pharmacology at
Prime Medicine, Inc.
January 2023 - Present
Vice President, Discovery and Non-Clinical Development at
Yarrow Biotechnology
August 2021 - January 2023
Executive Director, Translational Sciences, Quantitative Pharmacology, DMPK, and Preclinical Safety at
Sarepta Therapeutics
April 2020 - August 2021
Senior Director, Quantitative Pharmacology in the Translational Sciences Department at Sarepta at
Sarepta Therapeutics
April 2019 - April 2020
Senior Director, Pharmacology and DMPK at
Cyclerion
April 2019 - April 2019
Senior Director, Pharmacology and DMPK at
Ironwood Pharmaceuticals
September 2016 - March 2019
Director, In Vivo Pharmacology at
Novartis
July 2010 - September 2016
Associate Research Fellow at
Pfizer
June 1999 - July 2010
Senior Research Investigator at
Pfizer
June 1999 - July 2003
Principal Research Scientist at
Cardiovascularmetabolic
August 1998 - May 1999
Senior Scientist at
WYETH
March 1997 - March 1999
Senior Research Scientist II at
Cardiovascularmetabolic
February 1996 - July 1998
Senior Scientist at
American Cyanamid
September 1991 - March 1997
Senior Research Biologist at
American Cyanamid
September 1993 - February 1996
Research Biologist at
American Cyanamid
September 1991 - September 1993
Post-doctoral fellow at
Molecular And Cellular Biology
May 1989 - September 1991
John Hadcock
Education
Stony Brook University, Ph.D.
January 1985 - January 1989
State University of New York at Stony Brook, School of Medicine, Ph.D
January 1985 - January 1989
LIU Post, M.Sc Candidate
January 1981 - January 1983
LIU Post, B.Sc.
January 1977 - January 1981
Long Island University, C.W. Post College, B.Sc
January 1977 - January 1981
Frequently Asked Questions about John Hadcock
What is John Hadcock email address?
John Hadcock's primary email address is ********@primemedicine.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does John Hadcock work for?
John Hadcock is a Vice President, Nonclinical Development at Prime Medicine at Prime Medicine, Inc..
Where John Hadcock graduated from?
John Hadcock holds a degree in Pharmacology from Stony Brook University.
How can I directly contact John Hadcock?
To contact John Hadcock directly, you can use the email address ********@primemedicine.com. Complete contact information is available upon registration with Muraena.
Who is John Hadcock?
John Hadcock is an accomplished Vice President of Nonclinical Development at Prime Medicine, bringing over 30 years of extensive experience in drug discovery and development, particularly in RNA therapeutics and small molecules. He has been instrumental in leading teams that achieved five drug approvals and has a strong track record in advancing candidates through IND-enabling studies to clinical proof of concept. With expertise spanning various disease areas, including rare genetic disorders and metabolic diseases, John has published over 70 peer-reviewed works and holds 15 patents. His leadership roles in multiple organizations highlight his strategic vision and ability to drive innovation in the life sciences sector. He is also recognized for his contributions to regulatory processes, having served as a line function reviewer for numerous INDs and NDAs. John's commitment to scientific advancement is matched by his dedication to mentoring the next generation of scientists in the field.
John`s contact details
********@primemedicine.com
********@sarepta.com
Colleagues
Chief Technical Officer
Venture Advisor
Chief HR Officer at Prime Medicine
Senior Vice President, Head of Strategy and Corporate Operations
VP Business Development
Vice President
Chief Accounting Officer and SVP Finance
President and Chief Executive Office
Senior Vice President, Head of Regulatory Affairs
Vice President and Head of Hematology & Immunology